Table 3.
Sensory nerve conduction measurements
| Group | Pre-chemotherapy | Post-chemotherapy* | p-value# | |
|---|---|---|---|---|
|
Sural nerve |
|
|
|
|
| a-SAP(μV) |
Omega 3 |
13.27 (5.02) |
13.33 (5.91) |
.015 |
| |
Placebo |
13.70 (7.46) |
9.74 (5.96) |
|
| SCV(m/s) |
Omega 3 |
54.35 (7.13) |
54.79 (8.35) |
.514 |
| |
Placebo |
53.50 (6.79) |
52.52 (8.05) |
|
|
Ulnar nerve |
|
|
|
|
| a-SAP(μV) |
Omega 3 |
34.23 (14.85) |
24.53 (13.95) |
.454 |
| |
Placebo |
31.15 (14.02) |
21.53 (13.70) |
|
| SCV(m/s) |
Omega 3 |
57.30 (5.18) |
55.82 (6.35) |
.212 |
| Placebo | 55.80 (4.90) | 53.19 (7.29) |
a-SAP, sensory action potential amplitude; SCV, sensory conduction velocity.
* One month after the cessation of chemotherapy.
# p value is reported based on the analysis of covariance.